Skip to content

Clinical trials

Phase 1/2 Rectal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 1/2 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20192
20201
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Unknown status3
Completed2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Chinese Academy of Sciences1
Essen Biotech1
Fudan University1
Shanghai Minimally Invasive Surgery Center1
Shenzhen Ionova Life Sciences Co., Ltd.1
Sun Yat-sen University1
West China Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms11
Colonic Neoplasms3
Esophageal Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Colorectal Neoplasms1
Endometrial Neoplasms1
Erectile Dysfunction1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.